Moreover, we demonstrated that LMP and cathepsin D are involved in Tat-hspb1-induced cell death, establishing a basis for the further investigation of Tat-hspb1 cytotoxicity in an in vivo system and providing a potential application in the treatment of renal cancer. Here, TAT is linked to renal carcinoma.